NCT02855944 2023-06-09
ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
pharmaand GmbH
Phase 3 Completed
pharmaand GmbH
Japanese Gynecologic Oncology Group
King Faisal Specialist Hospital & Research Center
AGO Study Group